首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
SYNERGISTISCHE WIRKSTOFFKOMBINATIONEN ZUR KOSMETISCHEN ODER DERMATOLOGISCHEN PFLEGE DER HAUT ODER DER HAUTANHANGSGEBILDE
摘要
申请公布号
AT169211(T)
申请公布日期
1998.08.15
申请号
AT19940900762T
申请日期
1993.12.07
申请人
BEIERSDORF AKTIENGESELLSCHAFT
发明人
SAUERMANN, GERHARD;SCHOENROCK, UWE;SCHREINER, VOLKER;STAEB, FRANZ
分类号
A61K47/44;A61K8/00;A61K8/30;A61K8/36;A61K8/362;A61K8/365;A61K8/368;A61K8/37;A61K8/44;A61K8/49;A61K8/60;A61K8/64;A61K8/67;A61K8/98;A61K31/19;A61K31/195;A61K31/20;A61K31/32;A61K31/415;A61P17/00;A61P29/00;A61P43/00;A61Q3/00;A61Q5/00;A61Q5/12;A61Q19/00;A61Q19/08;(IPC1-7):A61K7/48
主分类号
A61K47/44
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Polyimid
VERFAHREN ZUR HERSTELLUNG FESTER TRÄGERTEILCHEN GLEICHER GRÖSSE FÜR POLYMERISATIONSKATALYSATOREN MIT HILFE ROTIERENDER PULVERISIERUNGSEINRICHTUNGEN
A METHOD OF MODIFYING A CRYSTALLINE MOLECULAR SIEVE MATERIAL
THERMOPLASTISCHE HARZZUSAMMENSETZUNG
GLUCOCORTICOID-SELECTIVE ANTI-INFLAMMATORY AGENTS
NOVEL DIMERIZING AGENTS, THEIR PRODUCTION AND USE
DEVICE FOR THE ABLATION OF TISSUE FROM AN INTERNAL SURFACE OF A BODY CAVITY
METHOD AND RADIO STATION FOR DATA TRANSMISSION
TRANSFER CONTROL POINT, MOBILE TELEPHONE FIXED TERMINAL, AND SWITCH CAPABLE OF BEING USED IN A DEVICE FOR CONNECTING A TELEPHONE SWITCH LOCATED IN AN ISOLATED COMMUNITY TO A FIXED TELEPHONE NETWORK
METHOD AND SYSTEM FOR SELECTING CONTROL CHANNELS FROM BASE STATIONS LOCATED NEAR A BORDER BETWEEN RADIO TELECOMMUNICATIONS NETWORKS
METHOD FOR LABELLING SAMPLE CONTAINERS
UNIVERSAL HYDRAULIC AND WIND TURBINE, AND APPLICATIONS
AN ELECTROACOUSTIC TRANSDUCER AND A DIAPHRAGM FOR AN ELECTROACOUSTIC TRANSDUCER
DIBORIDE COATED PRESSING SURFACES FOR ABRASION RESISTANT LAMINATE AND MAKING PRESSING SURFACES
Aufnahme- u. Aufgabevorrichtung für ein unter Druck stehendes Produkt
HALOGENATED PHENYL ALCOHOL AMIDES (LIGANDS OF GABAB RECEPTOR) HAVING AN ANTICONVULSANT ACTIVITY
MULTIPLE ACCESS METHOD AND SYSTEM
SYSTEM FOR DYNAMICALLY CHANGING DRAINING PRIORITY OF A RECEIVE FIFO
METHOD FOR ELIMINATING HALOGENATED COMPOUNDS CONTAINED IN A GAS OR LIQUID
ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS
